Clinical Infectious Diseases · 1982 · 81 citations · 10 references
Life SciencesMicrobiologyPharmacologyAntimicrobial PharmacotherapyAntimicrobial ResistanceMedical MicrobiologyAntibacterial ResistanceAntibiotic ResistanceAntimicrobial Drug InteractionsAntimicrobial PharmacodynamicsAntimicrobial Susceptibility TestingCombination Antimicrobial TherapyAdditive Antimicrobial EffectsBacteriostatic ActivityConcentration-dependent ActivityInoculum Concentration AdjustmentInoculum OptimizationInoculum PressurePseudomonas Species
The level of antimicrobial activity of 3-desacetylcefotaxime was found to be approximately eightfold lower than that of cefotaxime. Variation in the inhibitory effects of desacetylcefotaxime was species dependent. Desacetylcefotaxime was 1-2 log2 dilutions more active than cefotaxime against Pseudomonas acidovorans and Pseudomonas cepacia. Desacetylcefotaxime and cefotaxime were bactericidal, and their minimal inhibitory concentrations were influenced only slightly by increases in the inoculum concentration. Synergy (complete and partial) of 75.8% was noted with the combination. Only with strains of Morganella morganii was the combination antagonistic, but these results were not clinically significant; i.e., all strains remained susceptible to cefotaxime.
10
Pharmacokinetics of cefotaxime
Kwung P. Fu, P Aswapokee, Irwin Ho et al. · Antimicrobial Agents and Chemotherapy · 1979 · 71 citations · Full text
Human Pharmacology of Cefotaxime (HR 756), a New Cephalosporin
R Lüthy, R Münch, Jürg Blaser et al. · Antimicrobial Agents and Chemotherapy · 1979 · 61 citations · Full text